NewsWorld
PredictionsDigestsScorecardTimelinesArticles
NewsWorld
HomePredictionsDigestsScorecardTimelinesArticlesWorldTechnologyPoliticsBusiness
AI-powered predictive news aggregation© 2026 NewsWorld. All rights reserved.
Trending
CrisisInfrastructureStrikesIranTrumpNuclearFebruaryNewsMilitaryReachedLimitedDigestTimelineTrump'sDaysAnnounceDailyTariffsProtestsGreenlandChallengeEuropeanLongevityEmergency
CrisisInfrastructureStrikesIranTrumpNuclearFebruaryNewsMilitaryReachedLimitedDigestTimelineTrump'sDaysAnnounceDailyTariffsProtestsGreenlandChallengeEuropeanLongevityEmergency
All Articles
Hedge Funds Sold Most Global Equities Since April, Goldman Says
Bloomberg
Clustered Story
Published about 3 hours ago

Hedge Funds Sold Most Global Equities Since April, Goldman Says

Bloomberg · Feb 23, 2026 · Collected from RSS

Summary

Hedge funds’ net sales of global stocks reached the fastest pace since the tariff meltdown of early April 2025, according to traders on Goldman Sachs Group Inc.’s Prime Services Desk.


Share this story

Read Original at Bloomberg

Related Articles

Bloomberg7 days ago
Hedge Funds Buy Most Asian Stocks in a Decade, Goldman Says

Emerging and developed Asian markets saw the largest net-buying by hedge funds last week since Goldman Sachs Group Inc. Prime Services trading desk began tracking the data in 2016, as the region benefits from the optimism for AI infrastructure firms.

Bloomberg25 minutes ago
US Factory, Durable Goods Orders Declined in December

US Factory orders fell 0.7% in December, US Census Bureau data show, while durable goods orders were down 1.4%. Michael McKee reports on Bloomberg Television. (Source: Bloomberg)

Bloomberg38 minutes ago
Italy’s F2i Fund Nears €1 Billion on Europe Infrastructure Push

F2i SGR, Italy’s largest independent infrastructure fund manager, brought its credit assets close to €1 billion ($1.2 billion) as demand grows for private financing to modernize European infrastructure.

Bloombergabout 1 hour ago
Novo Nordisk CSO on New Obesity Shot Results and Drug Pipeline

Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly’s tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks on "Bloomberg Open Interest." (Source: Bloomberg)

Bloombergabout 1 hour ago
Alison Roman’s Plan to Conquer the Tomato Sauce Market

Alison Roman is a cult figure in the world of food media. Now she's putting her name on consumer goods, recently launching a new line of high-end jarred tomato sauce called, appropriately, A Very Good Sauce. Alison Roman joins Tracy Alloway and Joe Weisenthal on the Odd Lots podcast to discuss what she's learned about the consumer goods industry, from shipping to co-packing to designing a recipe that can be cooked in high volume. (Source: Bloomberg)

Bloombergabout 1 hour ago
Colombia Hawkish Pivot Masks Underlying Woes for Peso

Colombia’s peso is defying economic and political woes after a surprisingly hawkish pivot in monetary policy reinforced the dominant carry trade.